General Methods
All reactions were carried out in oven-dried glassware under an atmosphere of nitrogen with magnetic stirring, unless stated otherwise. For quantitative flash chromatography, technical grade solvents were used. For flash chromatography for analysis, HPLC grade solvents from Sigma-Aldrich were used. THF, Et 2 O, CH 3 CN, toluene, hexane and CH 2 Cl 2 were dried by passage over activated alumina under nitrogen atmosphere (H 2 O content < 30 ppm, Karl-Fischer titration). All chemicals were purchased from Strem, Acros, Aldrich, Fluka, VWR, Aplichem or Merck and used as such unless stated otherwise. Chromatographic purification was performed as flash chromatography using Macherey-Nagel silica 40-63, 60 Å, using the solvents indicated as eluent with 0.1-0.5 bar pressure. TLC was performed on Merck silica gel 60 F254 TLC glass plates or aluminium plates and visualized with UV light, permanganate stain, CAN stain or p-anisaldehyde stain. Melting points were measured on a Büchi B-540 melting point apparatus using open glass capillaries, the data is uncorrected. 1 H-NMR spectra were recorded on a Brucker DPX-400 400 MHz spectrometer in chloroform-d, DMSO-d6, CD 2 Cl 2 or CD 3 OD, all signals are reported in ppm with the internal chloroform signal at 7.26 ppm, the internal DMSO signal at 2.50 ppm, the internal CD 2 Cl 2 signal at 5.31 ppm, or the internal MeOD signal at 3.30 ppm as standard. The data are reported as follows: (s = singlet, d = doublet, t = triplet, q = quadruplet, qi = quintet, m = multiplet or unresolved, br = broad signal, coupling constant(s) in Hz, integration; interpretation). 13 C-NMR spectra were recorded with 1 H-decoupling on a Brucker DPX-400 100 MHz spectrometer in chloroform-d, DMSO-d6, CD 2 Cl 2 or CD 3 OD, all signals are reported in ppm with the internal chloroform signal at 77.0 ppm, the internal DMSO signal at 39.5 ppm, the internal CD 2 Cl 2 signal at 53.5 ppm or the internal MeOD signal at 49.0 ppm as standard. Infrared spectra were recorded on a JASCO FT-IR B4100 spectrophotometer with an ATR PRO410-S and a ZnSe prisma and are reported as cm -1 (w = weak, m = medium, s = strong, sh = shoulder). Gas chromatography and low resolution mass spectrometry measurements were performed on a Perkin-Elmer Clarus 600 gas chromatographe and mass spectrometer using a PerkinElmer Elite fused silica column (length: 30 m, diameter: 0.32 mm) and Helium as carrier gas. High resolution mass spectrometry measurements were performed by the mass spectrometry service of ISIC at the EPFL on a MICROMASS (ESI) Q-TOF Ultima API. HPLC measurements were done on a JASCO HPLC system with an AS2055 Autosampler, a PU 2089 Pump, a UV 2075 detector and a SEDEX 85 (SEDERE) detector using a CHIRALPAK IC, IB or IA column from DAICEL Chemical.
Preparation of Substrates

Synthesis of imides 5-Bromoisoindoline-1,3-dione (1b)
Following a modified procedure, 1 5-bromoisobenzofuran-1,3-dione (9) (500 mg, 2.20 mmol, 1.00 eq) and formamide (10) (8.82 mL, 220 mmol, 100 eq) were added in a 20 mL microwave vial and sealed with a microwave cap. The mixture was stirred until the product was completely dissolved. The mixture was heated 2 times at 200 °C for 30 sec with 10 sec pre-stirring, using a Biotage Initiator 2.0 microwave reactor. The mixture was cooled to 0 °C to induce crystallization and 10 mL of cold water was added into the tube. The white solid was filtrated over filter paper, washed with cold water (15 mL) and hexanes (20 mL) and dried under reduced pressure to afford 5-bromoisoindoline-1,3-dione (1b) as a colorless solid (394 mg, 1.75 mmol, 79% yield) which was used without further purification. Following a modified procedure, 3 a solution of 4-hydroxyphthalic acid (11) (2.00 g, 11.0 mmol, 1.00 eq), catalytic sulfuric acid (0.10 mL, 1.9 mmol, 0.17 eq) and MeOH (20.0 mL), was stirred at reflux for 7 h. under air. The solvent was removed under reduced pressure to afford crude dimethyl 4-hydroxyphthalate. The crude diester was dissolved in acetone (70 mL) and reacted with potassium carbonate (7.40 g, 53.5 mmol, 5.00 eq) at 50 °C for 20 min. Iodomethane (1.47 mL, 23.6 mmol, 2.20 eq) was added, and the mixture was stirred at reflux overnight. K 2 CO 3 was removed by filtration and the solvent was removed under reduced pressure to afford a colorless oil.
The crude was dissolved in acetone (16.0 mL) and a 11 M solution of sodium hydroxide, (6.00 mL, 66.0 mmol, 6.20 eq) was added, and the solution was stirred for 6 h. under air at rt. The solution was then acidified with 2 M HCl to pH 3, and concentrated under reduced pressure. Then, the crude 4-methoxyphthalic acid was dissolved into acetone (50 mL) and dried over MgSO 4 , filtered through a plug of cotton wool, and the solvent was removed in vacuo. The crude diacid was partitioned between 2 M NaOH (50 mL) and DCM (50 mL). The organic layer was extracted with NaOH 2 M (50 mL). The combined aqueous phase was cooled down to 0 °C and acidified with 37% HCl % to pH 3. The aqueous layer was then extracted five times with AcOEt (50 mL). The combined organic layers were dried over MgSO 4 and concentrated under reduced pressure to afford the crude diacid as a light brown solid (1.82 g).
A solution of crude 4-methoxyphthalic acid (1.82 g, 9.28 mmol, 1.00 eq) in acetic anhydride (25.0 mL, 266 mmol, 28.7 eq) was stirred at reflux for 21 h. Volatiles were removed in vacuo to afford a dark brown solid. The crude was dissolved in DCM (50 mL) and filtered through fritted glass to remove solid impurities. The solution was concentrated under reduced pressure and dried in vacuo to afford the anhydride 12 as a light brown solid (1.62 g, 9.08 mmol, 83% yield over 4 steps) 1 Following a modified procedure, 1 5-methoxyisobenzofuran-1,3-dione (12) (1.58 g, 8.84 mmol, 1.00 eq) and formamide (35.0 mL, 880 mmol, 100 eq) were divided between four 20 mL microwave vials sealed with a microwave cap. The mixture was stirred at rt until the product was completely dissolved, then heated 2 times at 200 °C for 30 sec with 10 sec pre-stirring, using Biotage Initiator 2.0 microwave reactor. The mixture was cooled to 0 °C to induce crystallization and cold water (10 mL) was added into each vial. The obtained solid was filtrated over filter paper, washed with water (15 mL) and hexanes (20 mL) and dried under reduced pressure to afford 5-methoxyisoindoline-1,3-dione (1e) as a beige solid (982 mg, 5.54 mmol, 63% yield) which was used without further purification. Following a modified procedure, 1 2,3-naphthalene dicarboxylic anhydride (13) (0.250 g, 1.26 mmol, 1.00 eq) and formamide (10) (10.1 mL, 252 mmol, 200 eq) were added in a 20 mL microwave vial and sealed with a microwave cap. The mixture was heated at 200 °C for 30 sec with 10 sec pre-stirring, using a Biotage Initiator 2.0 microwave reactor. The desired product crystalized spontaneously from the reaction mixture as white needles. Then 10 mL of water was added and the solid was filtered, washed with cold water (10 mL) and hexanes (10 mL) and dried under reduced pressure. Compound (1f) 
Vinylation of Imides N-(2-bromo-ethyl)-4,5-dichlorophthalimide (2)
Following a modified procedure, 7 4,5-dichlorophthalimide (1.00 g, 4.63 mmol, 1.00 eq.), anhydrous K 2 CO 3 (400 mg, 2.89 mmol, 0.625 eq.) and 1,3-dibromopropane (5.0 mL, 58 mmol, 13 eq.), were dissolved in DMF (10.0 mL). The mixture was stirred and heated at reflux for 10 h, then poured into H 2 O (100 mL) and extracted with CH 2 Cl 2 (3 X 30 mL). The combined extracts were then washed with brine (3 X 30 mL), dried over Na 2 SO 4 and the solvent evaporated under reduced pressure. The solid residue was purified by column chromatography (9:1 Hexane/Ethyl Acetate) to obtain N-(2-bromo-ethyl)-4,5-dichlorophthalimide (1.20 g, 3.72 mmol, 80 % yield) as a white solid. R f 0. 
General Procedures for the Vinylation Reactions (GP1) Method A (GP1A)
Following a modified procedure, 8 Na 2 PdCl 4 (2 mol%) was added to a stirred solution of the corresponding phthalimide (1.00 eq) in vinyl acetate (14) (27 eq) and the mixture was heated under reflux. The solvent was evaporated and the residue was purified by column chromatography to obtain solid compounds.
Method B (GP1B)
Palladium(II) chloride (10 mol%) and lithium chloride (10 mol% or 1.0 eq weighted in a glovebox), was added to a stirred solution of the corresponding phthalimide (1.00 eq) in vinyl acetate (14) (27 eq) and the mixture was heated under reflux. The mixture was cooled down to room temperature and the solvent was evaporated. The residue was purified by column chromatography to obtain solid compounds.
5,6-Dichloro-2-vinylisoindoline-1,3-dione (3a)
Following GP1A, 4,5-dichlorophthalimide (1a) (1.00 g, 4.63 mmol, 1.00 eq), vinyl acetate (14) (11.5 mL, 124 mmol, 26.8 eq) and Na 2 PdCl 4 (27.0 mg, 0.093 mmol, 2 mol%) were heated under reflux for 48 h. After solvent evaporation, the crude was purified by Biotage (SNAP Cartridge KP-Sil 25 g, 8:2 Hexane/AcOEt) to obtain (3a) as a yellow solid (1.12 g, 2.14 mmol, 72% b.r.s.m, 46% yield) and (0.357 g, 1.65 mmol, 36% reisolated yield) of the starting material. R f 0.53 (6:4 Hexane/AcOEt). m.p. 164.7 -166.6 °C. 1 H NMR (400 MHz, CDCl 3 ) δ 7.96 (s, 2 H, Ar), 6.84 (dd, 1 H, J = 16.4, 9.8 Hz, =CH), 6.09 (dd, 1 H, J = 16.4, 0.3 Hz, =CH), 5.10 (dd, 1 H, J = 9.8, 0.3 Hz, =CH).
13
C NMR (101 MHz, CDCl 3 ) δ 164. 6, 139.7, 130.8, 125.8, 123.7, 105.6 .
The NMR data for 3a corresponds to the reported values.
6 5-Bromo-2-vinylisoindoline-1,3-dione (3b) Following GP1B, 5-bromoisoindoline-1,3-dione (1b) (1.50 g, 6.64 mmol, 1.00 eq), PdCl 2 (118 mg, 0.664 mmol, 0.100 eq), LiCl (28.0 mg, 0.660 mmol, 0.100 eq, weighted in the glovebox) and vinyl acetate (14) (16.5 mL, 178 mmol, 26.8 eq) were heated under reflux for 28 h. After solvent evaporation, the crude was purified by silica gel chromatography (Hexane/AcOEt 20:1 to 15:1) to afford 5-bromo-2-vinylisoindoline-1,3-dione (3b) as a yellow solid (1.66 g, 6.59 mmol, 99% yield).
R f 0.47 (9:1 Hexane/AcOEt 4,5,6,7-Tetrafluoro-2-vinylisoindoline-1,3-dione (3c) Following GP1B, 4,5,6,7-tetrafluoroisoindoline-1,3-dione (1c) (500 mg, 2.82 mmol, 1.00 eq), PdCl 2 (40.0 mg, 0.228 mmol, 0.100 eq), LiCl (97.0 mg, 2.28 mmol, 1.00 eq, weighted in a glovebox) and vinyl acetate (14) (5.70 mL, 61.2 mmol, 26.8 eq) were heated under reflux for 48 h. The mixture was cooled down to room temperature and the solvent was evaporated under reduced pressure. 
5-Nitro-2-vinylisoindoline-1,3-dione (3d)
Following GP1B, 5-nitrosoindoline-1,3-dione (1d) (1.00 g, 5.20 mmol, 1.00 eq), PdCl 2 (92.0 mg, 0.520 mmol, 0.100 eq), LiCl (0.221 mg, 5.20 mmol, 1.00 eq, weighted in a glovebox) and vinyl acetate (14) (12.9 mL, 139 mmol, 26.8 eq) were heated under reflux for 20 h. The mixture was cooled down to room temperature and the solvent was evaporated under reduced pressure. The crude was purified by column chromatography using silica gel (Hexane/AcOEt 8:2 to 5:5) to afford 5-nitro-2-vinylisoindoline-1,3-dione (3d) as a bright yellow solid (1.14 g, 5.23 mmol, quantitative yield). 164.2, 152.1, 136.1, 133.1, 129.8, 125.0, 123.6, 119.2, 106.3. The NMR data for 3d corresponds to the reported values.
5-Methoxy-2-vinylisoindoline-1,3-dione (3e)
Following GP1B, 5-methoxyisoindoline-1,3-dione (1e) (980 mg, 5.53 mmol, 1.00 eq), PdCl 2 (98.0 mg, 0.553 mmol, 0.100 eq), LiCl (235 mg, 5.53 mmol, 1.00 eq, weighted in a glovebox) and vinyl acetate (14) (13.7 mL, 148 mmol, 26.8 eq) were heated under reflux for 24 h. The mixture was cooled down to room temperature and diluted with DCM/MeOH 4:1 (20 mL). Activated charcoal was added and the resulting suspension was filtered through a pad of Celite (DCM/MeOH 4:1 100 mL) and concentrated under reduced pressure. Purification by silica gel chromatography (pentane/AcOEt 90:10 to 75:25) afforded 5-methoxy-2-vinylisoindoline-1,3-dione (3e) as a colorless solid (828 mg, 4.08 mmol, 74% yield).
R 5, 166.3, 165.1, 134.4, 125.5, 124.0, 123.5, 120.6, 108.2, 104.0, 56.3 .
The NMR data for 3e corresponds to the reported values. The NMR data for 3f corresponds to the reported values. 1-Vinyl-1H-pyrrole-2,5-dione (3g) Following GP1B, maleimide (1g) (1.30 g, 13.4 mmol, 1.00 eq), PdCl 2 (0.237 g, 1.34 mmol, 0.100 eq), LiCl (57.0 mg, 1.34 mmol, 0.100 eq, weighted in a glovebox) and vinyl acetate (14) (33.2 mL, 359 mmol, 26.8 eq) were heated under reflux for 23 h. The mixture was cooled down to room temperature and the solvent was evaporated under reduced pressure. The crude was purified by Biotage (SNAP cartridge KP-Sil 50 g, 93:7 hexane/AcOEt to 40:60) afforded 1-vinyl-1H-pyrrole-2,5-dione (3g) as a bright yellow oil (1.74 g, 14.1 mmol, quantitative yield). R f 0.54 (7:3 Hexane/AcOEt). The NMR data for 3g corresponds to the reported values. 
1-Vinylpyrrolidine-2,5-dione (3h)
Following GP1A, succinimide (1h) (1.00 g, 10.1 mmol, 1.00 eq), vinyl acetate (14) (25.0 mL, 270 mmol, 26.8 eq) and Na 2 PdCl 4 (59.0 mg, 0.202 mmol, 2.00 mol%) were heated under reflux for 72 h. After solvent evaporation, the crude was purified by Biotage (SNAP Cartridge KP-Sil 50 g, 7:3 Hexane/AcOEt) to obtain (3h) as a yellow solid (1.22 g, 9.78 mmol, 97% yield). The NMR data for 3h corresponds to the reported values. 
Synthesis of Diazomalonates General Procedure for the Synthesis of Diazomalonates (GP2)
Following a modified procedure, 9 the corresponding malonate (1.00 eq), triethylamine (1.10 eq) and tosyl azide 10 (15) (1.10 eq) were dissolved in CH 3 CN. The solution was stirred at room temperature for 24 h. The solution was concentrated under reduced pressure and partitioned between CH 2 Cl 2 (30 mL) and H 2 O (30 mL), the layers were separated and the aqueous layer was extracted with CH 2 Cl 2 (1 X 20 mL). The organic layers were combined and dried over MgSO 4 . The crude was first filtered over a plug of silica gel (Hexane/Et 2 O 1:1) to remove most of the tosylamide formed during the reaction, then purified by column chromatography (Hexane/Et 2 O 90:10 to 80:20) to obtain the desired product.
Dimethyl-2-diazomalonate (4a)
Following GP2 and starting from dimethylmalonate (7.93 mL, 69.7 mmol, 1.00 eq), triethylamine (10.6 mL, 76.6 mmol, 1.10 eq) and tosyl azide (15) (15.1 g, 76.6 mmol, 1.10 eq) that were dissolved in CH 3 CN (100 mL), dimethyl-2-diazomalonate (4a) was obtained as yellow oil which solidified under storage at 4 °C (10.4 g, 65.5 mmol, 94% yield 
Bis(2,2,2-trifluoroethyl) 2-diazomalonate (4b)
Bis(2,2,2-trifluoroethyl) malonate (16) (5.00 g, 18.7 mmol, 1.00 eq), triethylamine (2.8 mL, 21 mmol, 1.1 eq) and 4-acetamidobenzenesulfonyl azide (17) (4.93 g, 20.5 mmol, 1.10 eq) were dissolved in acetonitrile (180 mL) at room temperature. After stirring the resulting mixture overnight, the suspension was filtered through a plug of cotton wool and the solvent was removed under reduced pressure. The crude was dissolved in DCM (200 mL), filtered through a plug of cotton wool, and partitioned between dichloromethane and water (200 mL). The two layers were separated and the aqueous layer was extracted with dichloromethane (2 x 150 mL). The combined organic layers were dried over MgSO 4 , concentrated under reduced pressure and dried under vacuum. Filtration through a plug of silica (AcOEt/hexane 1/1 + 1% NEt 3 , 500 mL) afforded bis(2,2,2-trifluoroethyl) 2-diazomalonate (4b) as a yellow oil (5.44 g, 18.5 mmol, 99% yield) which was not further purified.
R f 0.67 (6:4 Hexane/AcOEt); 1 H NMR (400 MHz, CDCl 3 ) δ 4.62 (q, 4 H, J C-F = 8.2 Hz, CH 2 ).
13
C NMR (101 MHz, CDCl 3 ) δ 158.7, 122.6 (q, J C-F = 277 Hz), 60.9 (q, J C-F = 37 Hz).
The NMR data for 4b corresponds to the reported values. 
Dibenzyl-2-diazomalonate (4c)
Following GP2 and starting from dibenzylmalonate (1.03 g, 4.62 mmol, 1.00 eq), triethylamine (0.71 mL, 5.1 mmol, 1.1 eq) and tosyl azide (15) (1.00 g, 5.08 mmol, 1.10 eq) that were dissolved in CH 3 CN (10.0 mL), dibenzyl-2-diazomalonate (4c) 
Synthesis of Aminocyclopropanes General Procedure for the of Synthesis of Aminocyclopropanes (GP3)
Following a modified procedure, 12 the corresponding N-vinyl-imide (1.00 eq) was dissolved in dry CH 2 Cl 2 (10.0 mL) and the solution was cooled down to 0 °C with an ice/water bath. Then, bis[rhodium( , , ', '-tetramethyl-1,3-benzenedipropionic acid)] (5) (0.1 mol%) was added in one portion. A solution in CH 2 Cl 2 (2.0 mL) of the corresponding malonate (1.20 eq) was added dropwise over 5 min. After the addition, the mixture was allowed to warm to rt and stirred overnight. The solvent is then removed under reduced pressure and the crude is directly purified by column chromatography.
Dimethyl 2-(5,6-dichloro-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (6a)
Following GP3, compound 6a was synthesized starting from N-vinyl-4,5-dichlorophthalimide (3a) (500 mg, 2.07 mmol, 1.00 eq), dimethyl-2-diazomalonate (4a) (392 mg, 2.48 mmol, 1.20 eq) and bis[rhodium( , , ', '-tetramethyl-1,3-benzenedipropionic acid)] (5) (1.6 mg, 2.1 μmol, 0.10 mol%). After solvent evaporation, the residue was purified by Biotage (SNAP Cartridge KP-Sil 25 g, 7:3 Hexane/AcOEt), to obtain a white solid (595 mg, 1.60 mmol, 77% yield). R f 0.27 (8:2 Hexane/AcOEt). m.p. 145.9 -148.1 °C. 1 H NMR (400 MHz, CDCl 3 ) δ 7.91 (s, 2 H, Phth), 3.83 (s, 3 H, OMe), 3.66 (dd, 1 H, J = 8.5, 6.5 Hz, N-CH), 3.63 (s, 3 H, OMe), 2.63 (t, 1 H, J = 6.5 Hz, CH 2 ), 2.04 (dd, 1 H, J = 8.5, 6.5 Hz, CH 2 ).
13 C NMR (101 MHz, CDCl 3 ) δ 168. 4, 167.1, 166.0, 139.5, 130.6, 125.7, 53.3, 53.2, 35.0, 33.1, 19.8. The NMR data for 6a corresponds to the reported values.
6
Dimethyl 2-(5-bromo-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (6b) Following GP3, compound 6b was synthesized starting from 5-bromo-2-vinylisoindoline-1,3-dione (3b) (50.0 mg, 0.198 mmol, 1.00 eq), dimethyl 2-diazomalonate (4a) (47.0 mg, 0.298 mmol, 1.50 eq) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (5) (0.3 mg, 0.4 μmol, 0.2 mol%). After solvent evaporation, the crude was purified by silica gel chromatography (hexane/AcOEt 75:25 to 70:30) to afford dimethyl 2- (5-bromo-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1 4, 167.0, 167.0, 166.5, 137.4, 133.1, 130.0, 129.4, 126.9, 124.9, 53.2, 53.0, 34.9, 33.1, 19.6. The NMR data for 6b corresponds to the reported values.
Dimethyl 2-(4,5,6,7-tetrafluoro-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (6c) Following GP3, compound 6c was synthesized starting from 4,5,6,7-tetrafluoro-2-vinylisoindoline-1,3-dione (3c) (0.260 g, 1.06 mmol, 1.00 eq), dimethyl 2-diazomalonate (4a) (0.252 g, 1.27 mmol, 1.20 eq) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (5) (0.80 mg, 1.0 μmol, 0.10 mol%). After solvent evaporation, the crude was purified by Biotage (SNAP Cartridge KP-Sil 10 g, 7:3 Hexane/AcOEt), to obtain a colorless solid (0.300 g, 0.801 mmol, 75% yield). R f 0.42 (8:2 Pentane/AcOEt). m.p. 86.2 -88.7 °C.
1 H NMR (400 MHz, CDCl 3 ) δ 3.80 (s, 3 H, OMe), 3.64 (s, 3 H, OMe), 3.55 (dd, 1 H, J = 8.5, 6.5 Hz, N-CH), 2.50 (t, 1 H, J = 6.6 Hz, CH 2 ), 2.03 (dd, 1 H, J = 8.5, 6.6 Hz, CH 2 ). 
Dimethyl 2-(5-nitro-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (6d)
Following GP3, compound 6d was synthesized starting from 5-nitro-2-vinylisoindoline-1,3-dione (3d) (0.500 g, 2.29 mmol, 1.00 eq), dimethyl 2-diazomalonate (4a) (0.544 g, 2.75 mmol, 1.20 eq) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (1.7 mg, 2.3 μmol, 0.10 mol%). After solvent evaporation, the crude was purified by Biotage (SNAP Cartridge KP-Sil 50 g, 7:3 Hexane/AcOEt), to obtain 6d as an off-white solid (712 mg, 2.04 mmol, 89% yield).
R 2, 167.1, 165.9, 165.6, 152.0, 135.9, 132.9, 129.6, 124.9, 119.0, 53.3, 53.2, 35.0, 33.1, 19.7. The NMR data for 6d corresponds to the reported values.
5
Dicarboxylate dimethyl 2-(5-methoxy-1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (6e) Following GP3, compound 6e was synthesized starting from 5-methoxy-2-vinylisoindoline-1,3-dione (3e) (0.130 g, 0.640 mmol, 1.00 eq), dimethyl 2-diazomalonate (4a) (0.121 g, 0.768 mmol, 1.20 eq) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (5) (0.5 mg, 0.6 μmol, 0.1 mol%). After solvent evaporation, the crude was purified by Biotage (SNAP Cartridge KP-Sil 10 g, 6:4 Hexane/AcOEt), to obtain 6e as a colorless solid (176 mg, 0.528 mmol, 83% yield). R f 0.15 (8:2 Pentane/AcOEt). m.p. 113.5 -117.8 °C.
1 H NMR (400 MHz, CDCl 3 ) δ 7.71 (d, 1 H, J = 8.3 Hz, Phth), 7.27 (d, 1 H, J = 2.2 Hz, Phth), 7.14 (dd, 1 H, J = 8.3, 2.3 Hz, Phth), 3.90 (s, 3 H, OMe), 3.80 (s, 3 H, 3.66 (dd, 1 H, J = 8.5, 6.6 Hz, 3.59 (s, 3 H, , 2.68 (t, 1 H, J = 6.5 Hz, CH 2 ), 1.99 (dd, 1 H, J = 8.5, 6.4 Hz, CH 2 ).
13 C NMR (101 MHz, CDCl 3 ) δ 168. 7, 167.8, 167.6, 167.0, 165.0, 134.1, 125.3, 123.4, 120.4, 108.1, 56.2, 53.2, 53.0, 35.0, 33.2, 19.7. The NMR data for 6e corresponds to the reported values.
Dimethyl 2-(1,3-dioxo-1H-benzo[f]isoindol-2(3H)-yl)cyclopropane-1,1-dicarboxylate (6f) Following GP3, compound 6f was synthesized starting from N-vinylphthalimide derivative 3f (100 mg, 0.448 mmol, 1.00 eq), dimethyl-2-diazomalonate (4a) (85.0 mg, 0.538 mmol, 1.20 eq) and bis [rhodium( , , ', '-tetramethyl-1,3-benzenedipropionic acid) ] (5) (0.4 mg, 5 μmol, 0.1 mol%). After solvent evaporation, the residue was purified by Biotage (SNAP Cartridge KP-Sil 10 g, 6:4 Hexane/AcOEt), to obtain 6f as a white solid (115 mg, 0.325 mmol, 73% yield). R f 0.39 (6:4 Hexane/AcOEt). m.p. 165.6 -167.5 °C.
1 H NMR (400 MHz, CDCl 3 ) δ 8.32 (s, 2 H, Ar), 8.04 (dd, 2 H, J = 6.2, 3.3 Hz, Ar), 7.69 (dd, 2 H, J = 6.2, 3.3 Hz, Ar), 3.83 (s, 3 H, OMe), 3.76 (dd, 1 H, J = 8.5, 6.7 Hz, 3.60 (s, 3 H, OMe) , 2.77 (t, 1 H, J = 6.5 Hz, CH 2 ), 2.07 (dd, 1 H, J = 8.5, 6.4 Hz, CH 2 ).
13 C NMR (101 MHz, CDCl 3 ) δ 168. 7, 167.7, 167.0, 135.7, 130.4, 129.4, 127.2, 125.1, 53.2, 53.1, 35.3, 33.3, 19.8 .
The NMR data for 6f corresponds to the reported values.
6 Dimethyl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)cyclopropane-1,1-dicarboxylate (6g) Following GP3, compound 6g was synthesized starting from 1-vinyl-1H-pyrrole-2,5-dione (3g) (50.0 mg, 0.406 mmol, 1.00 eq), dimethyl 2-diazomalonate (4a) (96.0 mg, 0.609 mmol, 1.50 eq) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (5) (0.7 mg, 0.9 μmol, 0.2 mol%). After solvent evaporation, the crude was purified by Biotage (SNAP cartridge KP-Sil 10 g, hexane/AcOEt 95:5 to 70:30) affording dimethyl 2-(2,5-dioxo-2,5-dihydro-1H-pyrrol-1-yl)cyclopropane-1,1-dicarboxylate (6g) as a colorless oil that solidified upon storage (66.9 mg, 0.264 mmol, 65% yield Following GP3, compound 6h was synthesized starting from N-vinyl-succinimide (3h) (500 mg, 4.00 mmol, 1.00 eq), dimethyl-2-diazomalonate (4a) (300 mg, 4.80 mmol, 1.20 eq) and bis[rhodium( , , ', '-tetramethyl-1,3-benzenedipropionic acid)] (5) (3.0 mg, 4.0 μmol, 0.10 mol%). After solvent evaporation, the residue was purified by Biotage (SNAP Cartridge KP-Sil 50 g, 5:5 Hexane/AcOEt), to obtain 6h as a yellow solid (801 mg, 3.14 mmol, 79% yield The NMR data for 6h corresponds to the reported values.
Bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (6i) Following GP3, compound 6i was synthesized starting from N-vinylphthalimide (535 mg, 3.09 mmol, 1.00 eq), bis(2,2,2-trifluoroethyl) 2-diazomalonate (4b) (1.00 g, 3.40 mmol, 1.10 eq) and bis[rhodium(α,α,α′,α′-tetramethyl-1,3-benzenedipropionic acid)] (5) (4.7 mg, 6.2 μmol, 0.20 mol%). After solvent evaporation, the residue was purified by silica gel chromatography (Hexane/AcOEt 95:5 to 75:25) to afford bis(2,2,2-trifluoroethyl) 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (6i) as a colorless solid (1.32 g, 3.01 mmol, 97% yield). R f 0.61 (6:4 Hexane/AcOEt). m.p. 76.3 -78.0 °C. 1 H NMR (400 MHz, CDCl 3 ) δ 7.87-7.82 (m, 2 H, Phth), 7.77-7.72 (m, 2 H, Phth), 4.61 (q, 2 H, J = 8.2 Hz, CH 2-CF 3 ), 4.50-4.30 (m, 2 H, CH 2-CF 3 ), 3.83 (dd, 1 H, J = 8.6, 6.9 Hz, CH-Phth), 2.90 (dd, 1 H, J = 6.8, 6.8 Hz, CH 2 ), 2.19 (dd, 1 H, J = 8.6, 6.6 Hz, CH 2 ). 7, 166.4, 164.5, 134.7, 131.4, 123.8, 122 .7 (q, J C-F = 277 Hz), 122.5 (q, J C-F = 277 Hz), 61.7 (q, J C-F = 37 Hz), 61.5 (q, J C-F = 37 Hz), 36.4, 32.7, 21 .0.
C NMR (101 MHz
The NMR data for 6i corresponds to the reported values.
6 Dibenzyl 2-(1,3-dioxoisoindolin-2-yl)cyclopropane-1,1-dicarboxylate (6j) Following GP3, compound 6j was synthesized starting from N-vinylphthalimide (180 mg, 1.04 mmol, 1.00 eq), dibenzyl-2-diazomalonate (4b) (387 mg, 1.25 mmol, 1.20 eq) and bis[rhodium( , , ', '-tetramethyl-1,3-benzenedipropionic acid)] (5) (0.8 mg, 1 μmol, 0.1 mol%). After solvent evaporation, the residue was purified by Biotage (SNAP Cartridge KP-Sil 10 g, 8:2 Hexane/AcOEt), to obtain 6j as a colorless oil (117 mg, 0.258 mmol, 25% yield). R f 0.36 (6:4 Hexane/AcOEt). 1 H NMR (400 MHz, CDCl 3 ) δ 7.70-7.67 (m, 2 H, Phth), 7.65-7.61 (m, 2 H, Phth), 7.27-7.24 (m, 5 H, Ar), 7.13-7.08 (m, 5 H, Ar), 5.18 (q, 2 H, J = 12.4 Hz, CH 2 -Ar), 4.94 (q, 2 H, J = 12.2 Hz, CH 2 -Ar), 3.68 (dd, 1 H, J = 8.5, 6.7 Hz, N-CH), 2.73 (t, 1 H, J = 6.5 Hz, CH 2 ), 1.99 (dd, 1 H, J = 8.5, 6.4 Hz, CH 2 ).
13 C NMR (101 MHz, CDCl 3 ) δ 168. 1, 167.8, 166.2, 135.4, 135.1, 134.3, 131.5, 128.7, 128.4, 128.4, 128.3, 128.1, 123.6, 67.8, 67.7, 35.3, 33.5, 19.8. 13 The NMR data for 6j corresponds to the reported values. 
Synthesis of Enol Ether 7
Triisopropyl((1-phenylvinyl)oxy)silane (7)
In an oven-dried flask sealed with a septum and under N 2 atmosphere, acetophenone (2.06 g, 17.1 mmol, 1.00 eq) in anhydrous THF (20 mL) is cooled down to -78 °C and a 1.9 M solution of NaHMDS (10.8 mL, 20.5 mmol, 1.20 eq) is added dropwise. The cold bath is removed and the pale yellow solution is stirred for 1 hour at room temperature. The reaction is cooled again to 0 °C and 1,3-dichloro-1,1,3,3-tetraisopropyldisiloxane (3.96 g, 20.5 mmol, 1.20 eq) is added dropwise. The reaction is stirred at room temperature for 5 h and the solvent is directly removed under reduced pressure. The resulting orange oil is purified by plug or by column chromatography on triethylamine-deactivated silica (99% Hexane, 1% Et 3 N) to obtain 7 as a colorless oil (4.7 g, 17 mmol, 99% yield) 1 
